Robust SARS-CoV- 2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments

Author(s):

Eva Zhang, Thi H.O. Nguyen, Lilith F. Allen, Lukasz Kedzierski, Louise C. Rowntree, So Young Chang, Wuji Zhang, Jennifer R. Habel, Isabelle J. Foo, Tejas Menon, Jeni Mitchell, Rupert W. Leong, Katherine Bond, Deborah A. Williamson, Katherine Kedzierska, Britt Christensen

Details:

Gut, Volume 73, Issue 4, 2023-03-06

Article Link: Click here

Affiliations:

• The Peter Doherty Institute for Infection and Immunity
• Royal Melbourne Hospital
• The Faculty of Medicine, Health and Human Sciences
• Faculty of Veterinary and Agricultural Sciences
• Walter and Eliza Hall Institute of Medical Research
• University of Melbourne
• Hokkaido University